GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,625,000 | +295.4% | 7,491 | +77.3% | 0.01% | +66.7% |
| Q3 2020 | $411,000 | -57.1% | 4,225 | -45.9% | 0.01% | -60.0% |
| Q2 2020 | $958,000 | +38.4% | 7,805 | -1.2% | 0.02% | -16.7% |
| Q1 2020 | $692,000 | +7.6% | 7,902 | +28.5% | 0.02% | +350.0% |
| Q4 2019 | $643,000 | -81.9% | 6,148 | -80.1% | 0.00% | -87.5% |
| Q3 2019 | $3,552,000 | -47.2% | 30,876 | -20.9% | 0.03% | -51.5% |
| Q2 2019 | $6,726,000 | +962.6% | 39,016 | +939.6% | 0.07% | +842.9% |
| Q1 2019 | $633,000 | -22.9% | 3,753 | -55.5% | 0.01% | -30.0% |
| Q4 2018 | $821,000 | +9.8% | 8,435 | +94.7% | 0.01% | +11.1% |
| Q3 2018 | $748,000 | +256.2% | 4,332 | +109.5% | 0.01% | +125.0% |
| Q3 2017 | $210,000 | – | 2,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |